➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKesson
Baxter
Mallinckrodt
Boehringer Ingelheim

Last Updated: October 27, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,691,411

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,691,411 protect, and when does it expire?

Patent 7,691,411 protects TIROSINT and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 7,691,411
Title:Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
Abstract: The present invention provides pharmaceutical formulation for thyroid hormones which allow safe and stable administration by mouth within the ambit of the narrow therapeutic index prescribed in the case of thyroid dysfunctions, as well as procedures for obtaining them.
Inventor(s): Di Martino; Alessandro (Casalzuigno, IT), Mateo; Angel (Segrate, IT), Garavani; Alberto (Ponte Capriasca, CH), Marchiorri; Maurizio (Valbrona, IT)
Assignee: Altergon S.A. (Lugano, CH)
Application Number:10/746,386
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,691,411
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 7,691,411

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-013 Aug 1, 2007 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-002 Oct 13, 2006 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-003 Oct 13, 2006 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-004 Oct 13, 2006 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-010 Oct 2, 2009 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-005 Oct 13, 2006 RX Yes No   Start Trial   Start Trial Y   Start Trial
Institut Biochimique TIROSINT levothyroxine sodium CAPSULE;ORAL 021924-008 Oct 2, 2009 RX Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,691,411

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 447939   Start Trial
Canada 2454050   Start Trial
Germany 60329968   Start Trial
Denmark 1433478   Start Trial
European Patent Office 1433478   Start Trial
Spain 2334777   Start Trial
Italy MI20022777   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKinsey
Mallinckrodt
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.